dc.contributor.advisor | Epstein, David Mark | |
dc.contributor.advisor | Espín Balbino, Jaime | |
dc.contributor.author | Rejón Parrilla, Juan Carlos | |
dc.contributor.other | Universidad de Granada. Programa de Doctorado en Ciencias Económicas y Empresariales | es_ES |
dc.date.accessioned | 2024-06-04T10:45:58Z | |
dc.date.available | 2024-06-04T10:45:58Z | |
dc.date.issued | 2024 | |
dc.date.submitted | 2024-04-04 | |
dc.identifier.citation | Rejón Parrilla, Juan Carlos. The value and measurement of innovation in health technology assessment and its impact on public financing of medicines. Granada: Universidad de Granada, 2024. [https://hdl.handle.net/10481/92318] | es_ES |
dc.identifier.isbn | 9788411952972 | |
dc.identifier.uri | https://hdl.handle.net/10481/92318 | |
dc.description.sponsorship | Tesis Univ. Granada. | es_ES |
dc.description.sponsorship | Chapters I, II and III of this PhD thesis received support from the CEAT project (research project PID2019.105597RA.I00 financed by the Spanish Ministry of Science and Innovation/ National Research Agency MCIN/ AEI/10.13039/501100011033). The funders had no role in the study. | es_ES |
dc.format.mimetype | application/pdf | en_US |
dc.language.iso | eng | es_ES |
dc.publisher | Universidad de Granada | es_ES |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.title | The value and measurement of innovation in health technology assessment and its impact on public financing of medicines | es_ES |
dc.type | doctoral thesis | es_ES |
europeana.type | TEXT | en_US |
europeana.dataProvider | Universidad de Granada. España. | es_ES |
europeana.rights | http://creativecommons.org/licenses/by-nc-nd/3.0/ | en_US |
dc.rights.accessRights | open access | es_ES |
dc.type.hasVersion | VoR | es_ES |